{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:48:00Z","timestamp":1790430480879,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.radonc.2017.10.008","type":"journal-article","created":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T13:31:22Z","timestamp":1508506282000},"page":"125-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["SDF-1\/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy"],"prefix":"10.1016","volume":"126","author":[{"given":"Chiara","family":"De-Colle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Menegakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"M\u00f6nnich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Welz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Boeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bence","family":"Sipos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul-Stefan","family":"Mauz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Tinhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Budach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehad","family":"Abu Jawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stuschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Balermpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"R\u00f6del","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca-Ligia","family":"Grosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Belka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Ganswindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffi","family":"Pigorsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Combs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Lohaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annett","family":"Linge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mechthild","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2017.10.008_b0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer Statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2017.10.008_b0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","article-title":"An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer","volume":"21","author":"Adelstein","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.10.008_b0015","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1200\/JCO.2004.12.193","article-title":"Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy","volume":"22","author":"Huguenin","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.10.008_b0020","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2017.10.008_b0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Group M-NC. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.10.008_b0030","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1200\/JCO.2008.20.2853","article-title":"Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck","volume":"27","author":"Lassen","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.10.008_b0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.radonc.2011.02.010","article-title":"The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial","volume":"100","author":"Lassen","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.10.008_b0040","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.radonc.2016.11.008","volume":"121","author":"Linge","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.10.008_b0045","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.radonc.2014.11.011","volume":"113","author":"Lohaus","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.10.008_b0050","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1158\/1078-0432.CCR-15-1990","article-title":"Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: a Multicenter Study of the DKTK-ROG","volume":"22","author":"Linge","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2017.10.008_b0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ctro.2016.10.002","article-title":"Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy","volume":"1","author":"Linge","year":"2016","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2017.10.008_b0060","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejca.2016.01.003","article-title":"Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation","volume":"57","author":"Tinhofer","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2017.10.008_b0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ijc.29683","article-title":"CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: a multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)","volume":"138","author":"Balermpas","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2017.10.008_b0070","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.30770","article-title":"The PD-1\/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: a multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)","author":"Balermpas","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2017.10.008_b0075","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrc.2016.18","article-title":"Radiation oncology in the era of precision medicine","volume":"16","author":"Baumann","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2017.10.008_b0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ctro.2017.06.004","article-title":"SDF-1\/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy","volume":"5","author":"De-Colle","year":"2017","journal-title":"Clinical and Translational Radiation Oncology."},{"key":"10.1016\/j.radonc.2017.10.008_b0085","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc1388","article-title":"Cancer and the chemokine network","volume":"4","author":"Balkwill","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2017.10.008_b0090","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/path.3029","article-title":"The chemokine system and cancer","volume":"226","author":"Balkwill","year":"2012","journal-title":"J Pathol"},{"key":"10.1016\/j.radonc.2017.10.008_b0095","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1158\/1078-0432.CCR-10-2636","article-title":"CXCL12 (SDF1alpha)-CXCR4\/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?","volume":"17","author":"Duda","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2017.10.008_b0100","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc3078","article-title":"Chemotaxis in cancer","volume":"11","author":"Roussos","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2017.10.008_b0105","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/carcin\/bgn108","article-title":"CXCL12\/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1\/2\/AP-1 pathway","volume":"29","author":"Tan","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.radonc.2017.10.008_b0110","first-page":"61","article-title":"CXCR4 expression is associated with lymph-node metastasis of oral squamous cell carcinoma","volume":"28","author":"Ishikawa","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1016\/j.radonc.2017.10.008_b0115","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1158\/1078-0432.CCR-04-1470","article-title":"Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma","volume":"11","author":"Katayama","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2017.10.008_b0120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1158\/1541-7786.MCR-06-0368","article-title":"Involvement of an autocrine stromal cell derived factor-1\/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma","volume":"5","author":"Uchida","year":"2007","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.radonc.2017.10.008_b0125","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.canlet.2004.04.035","article-title":"CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma","volume":"214","author":"Samara","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1016\/j.radonc.2017.10.008_b0130","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0714.2008.00671.x","article-title":"CXCR-4 knockdown by small interfering RNA inhibits cell proliferation and invasion of oral squamous cell carcinoma cells","volume":"38","author":"Hong","year":"2009","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.radonc.2017.10.008_b0135","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/mt.2011.257","article-title":"RNAi targeting CXCR4 inhibits tumor growth through inducing cell cycle arrest and apoptosis","volume":"20","author":"Yu","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.radonc.2017.10.008_b0140","doi-asserted-by":"crossref","first-page":"7518","DOI":"10.1158\/0008-5472.CAN-06-2263","article-title":"CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models","volume":"67","author":"Yoon","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2017.10.008_b0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4248\/IJOS.09059","article-title":"CXCL12\/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3\/Bcl10\/Malt1 complex","volume":"1","author":"Rehman","year":"2009","journal-title":"Int J Oral Sci."},{"key":"10.1016\/j.radonc.2017.10.008_b0150","first-page":"1133","article-title":"Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1\/CXCR4 system in oral squamous cell carcinoma cells","volume":"29","author":"Onoue","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1016\/j.radonc.2017.10.008_b0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1158\/1541-7786.MCR-10-0386","article-title":"CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway","volume":"9","author":"Yu","year":"2011","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.radonc.2017.10.008_b0160","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/labinvest.3700190","article-title":"Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinoma","volume":"84","author":"Uchida","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.radonc.2017.10.008_b0165","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1158\/1078-0432.CCR-04-1798","article-title":"The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma","volume":"11","author":"Hu","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2017.10.008_b0170","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1007\/s13277-015-4464-1","article-title":"Expression of chemokine receptor CXCR4 is closely correlated with clinical outcome in human nasopharyngeal carcinoma","volume":"37","author":"Tao","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.radonc.2017.10.008_b0175","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.oraloncology.2012.06.010","article-title":"Prognostic value of the chemokine receptor CXCR4 and epithelial-to-mesenchymal transition in patients with squamous cell carcinoma of the mobile tongue","volume":"48","author":"Albert","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2017.10.008_b0180","first-page":"1355","article-title":"Role of Twist in head and neck carcinoma with lymph node metastasis","volume":"28","author":"Ou","year":"2008","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2017.10.008_b0185","first-page":"392","article-title":"Gao Z","volume":"25","author":"Yin","year":"2007","journal-title":"Hua Xi Kou Qiang Yi Xue Za Zhi"},{"key":"10.1016\/j.radonc.2017.10.008_b0190","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.oraloncology.2011.07.021","article-title":"Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinoma","volume":"47","author":"Clatot","year":"2011","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2017.10.008_b0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00066-015-0892-5","article-title":"Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma","volume":"192","author":"Rave-Frank","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2017.10.008_b0200","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1007\/s00405-016-4144-9","article-title":"Expression of the CXCL12\/CXCR4 chemokine axis predicts regional control in head and neck squamous cell carcinoma","volume":"273","author":"Leon","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.radonc.2017.10.008_b0205","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.18632\/oncotarget.3217","article-title":"CXCR4 over-expression and survival in cancer: a system review and meta-analysis","volume":"6","author":"Zhao","year":"2015","journal-title":"Oncotarget."},{"key":"10.1016\/j.radonc.2017.10.008_b0210","doi-asserted-by":"crossref","first-page":"e31226","DOI":"10.1371\/journal.pone.0031226","article-title":"CXCR4 expression in prostate cancer progenitor cells","volume":"7","author":"Dubrovska","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.radonc.2017.10.008_b0215","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.3892\/or.2013.2380","article-title":"SDF-1-CXCR4 axis: cell trafficking in the cancer stem cell niche of head and neck squamous cell carcinoma","volume":"29","author":"Faber","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.radonc.2017.10.008_b0220","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3892\/or.2012.2171","article-title":"Functional effects of SDF-1alpha on a CD44(+) CXCR4(+) squamous cell carcinoma cell line as a model for interactions in the cancer stem cell niche","volume":"29","author":"Faber","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.radonc.2017.10.008_b0225","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/onc.2012.37","article-title":"Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells","volume":"32","author":"Jung","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.radonc.2017.10.008_b0230","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3109\/09553002.2014.906766","article-title":"CXCR4 as biomarker for radioresistant cancer stem cells","volume":"90","author":"Trautmann","year":"2014","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2017.10.008_b0235","doi-asserted-by":"crossref","first-page":"34494","DOI":"10.18632\/oncotarget.5417","article-title":"Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma","volume":"6","author":"Kurth","year":"2015","journal-title":"Oncotarget."},{"key":"10.1016\/j.radonc.2017.10.008_b0240","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.oraloncology.2015.08.017","article-title":"Tumor necrosis factor alpha induces myofibroblast differentiation in human tongue cancer and promotes invasiveness and angiogenesis via secretion of stromal cell-derived factor-1","volume":"51","author":"Zhou","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2017.10.008_b0245","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2121-15-15","article-title":"Intracellular trafficking and endocytosis of CXCR4 in fetal mesenchymal stem\/stromal cells","volume":"15","author":"Pelekanos","year":"2014","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.radonc.2017.10.008_b0250","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/hed.23217","article-title":"Focus on the role of the CXCL12\/CXCR4 chemokine axis in head and neck squamous cell carcinoma","volume":"35","author":"Albert","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2017.10.008_b0255","doi-asserted-by":"crossref","first-page":"14259","DOI":"10.18632\/oncotarget.7423","article-title":"BK K+ channel blockade inhibits radiation-induced migration\/brain infiltration of glioblastoma cells","volume":"7","author":"Edalat","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.radonc.2017.10.008_b0260","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1158\/1541-7786.MCR-11-0592","article-title":"Akt promotes post-irradiation survival of human tumor cells through initiation, progression, and termination of DNA-PKcs-dependent DNA double-strand break repair","volume":"10","author":"Toulany","year":"2012","journal-title":"Mol Cancer Res"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814017326488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814017326488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T06:03:24Z","timestamp":1603173804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814017326488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0167814017326488"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2017.10.008","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SDF-1\/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2017.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}